Continuous subcutaneous infusion of Remodulin™, a prostacyclin analogue, in patients with pulmonary arterial hypertension:: Long-term outcome

被引：0
|
作者：
McLaughlin, V
Sitbon, O
Sigman, J
Blackburn, S
机构：
[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[2] Hop Antoine Beclere, Clamart, France
[3] United Therapeut Corp, Res Triangle Pk, NC USA
[4] United Therapeut Corp, Remodulin Study Grp, Res Triangle Pk, NC USA
来源：
CIRCULATION | 2001年 / 104卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1203
引用
收藏
页码：250 / 250
页数：1
相关论文
共 50 条
  • [21] The prostacyclin analogue treprostinil in the treatment of pulmonary arterial hypertension
    Pedersen, Mia Lindegaard
    Krueger, Marcus
    Grimm, Daniela
    Infanger, Manfred
    Wehland, Markus
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 (01) : 32 - 42
  • [22] Long-term safety and outcome of subcutaneous and intravenous treprostinil in patients with severe chronic pulmonary hypertension
    Harutyunova, Satenik
    Benkamin, Nicola
    Eichstaedt, Christina
    Marra, Alberto Maria
    Xanthouli, Panagiota
    Egenlauf, Benjamin
    Gruenig, Ekkehard
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [23] Long-term use of continuous subcutaneous insulin infusion
    Pickup, John C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 74 : S101 - S103
  • [24] CONTINUOUS SUBCUTANEOUS INSULIN INFUSION - A LONG-TERM STUDY
    LOMBARDO, A
    SCAVINO, S
    SCORNAVACCA, G
    OLIVA, G
    SIPIONE, C
    CACCIOLA, R
    MOTTA, L
    ACTA DIABETOLOGICA LATINA, 1986, 23 (01): : 1 - 12
  • [25] LONG-TERM TREATMENT OF PRIMARY PULMONARY-HYPERTENSION WITH CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN)
    HIGENBOTTAM, T
    WELLS, F
    WHEELDON, D
    WALLWORK, J
    LANCET, 1984, 1 (8385): : 1046 - 1047
  • [26] Efficacy of long-term subcutaneous infusion of UT-15 in primary pulmonary hypertension
    Barst, RJ
    Horn, EM
    Widlitz, AC
    Goudie, SM
    Kerstein, D
    Berman-Rosenzweig, E
    Blackburn, SD
    EUROPEAN HEART JOURNAL, 2000, 21 : 315 - 315
  • [27] Long-term follow up after successful discontinuation of prostacyclin analogues in patients with pulmonary arterial hypertension (PAH)
    Zavala, EDG
    Minai, O
    Bair, N
    Banjac, S
    Arroliga, A
    CHEST, 2005, 128 (04) : 161S - 161S
  • [28] The effect of long-term prostacyclin on exercise capacity in patients with pulmonary arterial hypertension associated with congenital heart defects
    Rosenzweig, EB
    Moore, K
    Kerstein, D
    Gates, G
    Barst, RJ
    Garofano, R
    EUROPEAN HEART JOURNAL, 2001, 22 : 320 - 320
  • [29] PRACTICAL EXPERIENCE OF LONG-TERM PROSTACYCLIN IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION
    JONES, K
    HIGENBOTTAM, T
    WALLWORK, J
    THORAX, 1985, 40 (03) : 232 - 233
  • [30] Long-term safety and outcome of subcutaneous and intravenous treprostinil treatment in patients with severe chronic pulmonary hypertension
    Harutyunova, S.
    Benjamin, N.
    Eichstaedt, C.
    Marra, A. M.
    Xanthouli, P.
    Egenlauf, B.
    Gruenig, E.
    PNEUMOLOGIE, 2020, 74 : S125 - S125
12345